What is Genomics?
The sequencing of the Human Genome at the start of the 21st century uncovered the series of letters – chemical codes – that make up our genetic material. That was an important step. But learning how to interpret and, in some cases modify, that genetic code is even more significant.
That’s genomics – reading, understanding and editing the genetic instructions, or DNA, that make up each one of us.
Genomics nation 2022
Innovative UK genomics companies are vital to the future wealth of our nation. With the right investment, skilled people and partnership working with the NHS family, UK SMEs are ideally placed to have an impact on the global stage.
The UK Genomics sector
To help investors and policymakers understand the opportunities Genomics presents in the UK, in July 2021, we produced a benchmarking study of the size and strengths of the UK Genomics sector.
To learn more about Genomics, you can download Genomics: A guide to genomics and UK excellence in the field, which contains input from BIA members at the Wellcome Genome Campus, Congenica, Eagle Genomics, Genomics plc, Global Gene Corp, Oxford Nanopore, New Gene, Cambridge Cancer Genomics, Cambridge Epigenetix.
Celebrating UK Bioscience | Genomics
Alongside the report we have also produced a video that features case studies from Wellcome Genome Campus, Congenica, Oxford Nanopore and Microbiotica. This video explores the advances made in the field of genomics in the last number of years, and the future of the sector in the UK as technology moves from strength to strength.
We would like to thank the BIA's Genomics Advisory Committee for supporting the production of the video and guide.